Cengild Medical Berhad (KLSE:CENGILD)
Malaysia
· Delayed Price · Currency is MYR 0.210
-0.005 (-2.33%)
At close: Mar 6, 2026
Cengild Medical Berhad Income Statement
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2018 |
| Revenue | 74.93 | 80 | 66.82 | 70.28 | 64.44 | 63.47 | Upgrade
|
| Revenue Growth (YoY) | -0.59% | 19.72% | -4.92% | 9.06% | 1.53% | 62.00% | Upgrade
|
| Cost of Revenue | 40.14 | 43.12 | 35.75 | 39.55 | 38.39 | 36.79 | Upgrade
|
| Gross Profit | 34.79 | 36.87 | 31.07 | 30.73 | 26.05 | 26.68 | Upgrade
|
| Selling, General & Admin | 23.41 | 22.05 | 17.86 | 16.24 | 14.48 | 12.21 | Upgrade
|
| Other Operating Expenses | 0.42 | - | - | - | - | - | Upgrade
|
| Operating Expenses | 24.32 | 22.54 | 17.86 | 16.26 | 14.48 | 12.21 | Upgrade
|
| Operating Income | 10.47 | 14.33 | 13.21 | 14.46 | 11.57 | 14.47 | Upgrade
|
| Interest Expense | -0.34 | -0.39 | -0.6 | -0.73 | -0.85 | -1.22 | Upgrade
|
| Earnings From Equity Investments | 0.87 | 0.47 | -0.35 | - | - | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.59 | 3.59 | 4.48 | 3.65 | 1.39 | 0.22 | Upgrade
|
| EBT Excluding Unusual Items | 14.59 | 18.01 | 16.73 | 17.37 | 12.11 | 13.47 | Upgrade
|
| Pretax Income | 14.59 | 18.01 | 16.73 | 17.37 | 12.11 | 13.47 | Upgrade
|
| Income Tax Expense | 3.47 | 4.44 | 4.77 | 4.09 | 2.72 | 3.46 | Upgrade
|
| Earnings From Continuing Operations | 11.12 | 13.57 | 11.97 | 13.29 | 9.39 | 10 | Upgrade
|
| Earnings From Discontinued Operations | -1.44 | -2.51 | -0.89 | - | - | - | Upgrade
|
| Net Income | 9.69 | 11.06 | 11.08 | 13.29 | 9.39 | 10 | Upgrade
|
| Net Income to Common | 9.69 | 11.06 | 11.08 | 13.29 | 9.39 | 10 | Upgrade
|
| Net Income Growth | -15.77% | -0.19% | -16.64% | 41.50% | -6.13% | 153.15% | Upgrade
|
| Shares Outstanding (Basic) | 833 | 833 | 833 | 819 | 644 | 600 | Upgrade
|
| Shares Outstanding (Diluted) | 833 | 833 | 834 | 826 | 645 | 600 | Upgrade
|
| Shares Change (YoY) | -0.02% | -0.11% | 1.00% | 27.94% | 7.56% | 4700.00% | Upgrade
|
| EPS (Basic) | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | Upgrade
|
| EPS Growth | -15.77% | -0.19% | -17.39% | 10.46% | -12.59% | -94.73% | Upgrade
|
| Free Cash Flow | -57.26 | -21.18 | -2.8 | 11.78 | 14.9 | 12.6 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.03 | -0.00 | 0.01 | 0.02 | 0.02 | Upgrade
|
| Dividend Per Share | 0.007 | 0.010 | 0.007 | 0.007 | 0.004 | - | Upgrade
|
| Dividend Growth | -27.83% | 31.08% | - | 100.00% | - | - | Upgrade
|
| Gross Margin | 46.43% | 46.10% | 46.50% | 43.72% | 40.42% | 42.03% | Upgrade
|
| Operating Margin | 13.97% | 17.91% | 19.77% | 20.58% | 17.95% | 22.79% | Upgrade
|
| Profit Margin | 12.93% | 13.82% | 16.58% | 18.91% | 14.57% | 15.76% | Upgrade
|
| Free Cash Flow Margin | -76.41% | -26.48% | -4.19% | 16.77% | 23.12% | 19.85% | Upgrade
|
| EBITDA | 15.5 | 19.39 | 15.76 | 16.33 | 14.56 | 17.56 | Upgrade
|
| EBITDA Margin | 20.68% | 24.23% | 23.58% | 23.23% | 22.60% | 27.67% | Upgrade
|
| D&A For EBITDA | 5.03 | 5.06 | 2.55 | 1.87 | 2.99 | 3.1 | Upgrade
|
| EBIT | 10.47 | 14.33 | 13.21 | 14.46 | 11.57 | 14.47 | Upgrade
|
| EBIT Margin | 13.97% | 17.91% | 19.77% | 20.58% | 17.95% | 22.79% | Upgrade
|
| Effective Tax Rate | 23.76% | 24.65% | 28.48% | 23.52% | 22.48% | 25.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.